Trade MXCT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
MaxCyte, Inc. (MXCT) is trading at US$1.27, up 0.40% today as of Sep 4, 13:36 EDT. The company has a market capitalisation of US$142.42M. Over the past 52 weeks, MXCT has traded between US$0.64 and US$1.87. On Syfe you can trade MXCT with $0 commission and add it to your watchlist.
| Previous close | US$1.26 |
|---|---|
| Market cap | US$142.42M |
| 52-week range | US$0.64 – US$1.87 |
| Volume | 425.79K |
| Exchange | US |
Add to Watchlist
Set Price Alert
MaxCyte, Inc.
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.
Year: 2019
MaxCyte Enters Technology License Partnership With Genentech
Jul 21, 1:29 PM · MT Newswires
MaxCyte, Inc. (MXCT) stock is trading at US$1.27, +0.40% from the previous close of US$1.26.
The market cap for MaxCyte, Inc. (MXCT) stock is approximately US$142.42M.
The 52-week high for MaxCyte, Inc. (MXCT) stock is US$1.87.
The 52-week low for MaxCyte, Inc. (MXCT) stock is US$0.64.
MaxCyte, Inc. (MXCT) does not currently pay a dividend.
Stay on top of MXCT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
